Med-tech company iCAD announced it would incorporate Google Health’s mammography AI technology into its breast-imaging solutions thanks to a strategic development and commercialization agreement.
Cancer detection and therapy solutions platform iCAD will utilize Google’s AI breast-imaging technology in its portfolio, including its clinical decision support tool for breast cancer risk-estimation ProFound AI Risk.
The deal will bring Google’s AI technology into clinical practice. This marks the first time the Alphabet subsidiary’s AI research model has been licensed with a mammography vendor.
The New Hampshire-based company will also utilize Google Cloud’s infrastructure to accelerate the commercialization of its cloud-based offerings.
THE LARGER TREND
In 2020, a study was published in Nature showing how the tech giant’s deep learning-based AI system fared compared to radiologists in detecting breast cancer during the early stages of the disease.
Results showed the AI tool decreased the rate of false positives by 5.7% in the U.S.